文献速递性腺与生殖内分泌肥胖与代谢综合征

多囊卵巢综合征中的脂肪组织功能障碍

Adipose Tissue Dysfunction in Polycystic Ovary Syndrome.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该系统综述聚焦多囊卵巢综合征(PCOS)中的脂肪组织功能障碍,优先纳入直接评估脂肪组织功能的研究,并探讨针对脂肪组织功能障碍的治疗。综述发现脂肪组织 dysfunction 涉及储存容量失调、缺氧、增生、脂肪生成受损、胰岛素信号和葡萄糖转运受损、脂解失调、脂肪因子和细胞因子失调、表观遗传调控及线粒体功能障碍等机制,脂肪细胞葡萄糖转运体4表达和含量降低是 consistent 异常。作者认为脂肪组织功能障碍较脂肪分布和脂肪过多更促进PCOS代谢和炎症异常,但许多研究数据矛盾、不清晰或有限,亟需进一步研究。

要点

  • 脂肪组织功能障碍涉及储存容量失调、缺氧、增生、脂肪生成受损、胰岛素信号和葡萄糖转运受损、脂解失调、脂肪因子和细胞因子失调、表观遗传调控及线粒体功能障碍等机制。
  • 脂肪细胞葡萄糖转运体4表达和含量降低导致脂肪组织胰岛素介导的葡萄糖转运减少,是 consistent 异常,尽管胰岛素结合或IRS/PI3K/Akt信号无改变。
  • PCOS患者脂肪组织对细胞因子/趋化因子的脂联素分泌反应与对照相比受影响。

核心结论

  • 脂肪组织功能障碍较脂肪分布和脂肪过多更促进PCOS的代谢和炎症异常。
  • 许多研究提供矛盾、不清晰或有限的数据,凸显该重要领域亟需额外研究。

研究设计与样本

  • 系统综述,优先纳入直接评估PCOS中脂肪组织功能的研究,并探讨针对脂肪组织功能障碍治疗PCOS的研究。

主要发现

  • PCOS中脂肪组织功能障碍机制包括储存容量失调、缺氧和增生;脂肪生成受损;胰岛素信号和葡萄糖转运受损;脂解失调和非酯化游离脂肪酸(NEFAs)动力学异常;脂肪因子和细胞因子失调及亚急性炎症;表观遗传失调;线粒体功能障碍及内质网和氧化应激。
  • 脂肪细胞葡萄糖转运体4表达和含量降低导致脂肪组织胰岛素介导的葡萄糖转运减少,是 consistent 异常,尽管胰岛素结合或IRS/PI3K/Akt信号无改变。
  • PCOS患者脂肪组织对细胞因子/趋化因子的脂联素分泌反应与对照相比受影响。
  • 通过DNA甲基化和microRNA调控的表观遗传调节似乎是PCOS中脂肪组织功能障碍的重要机制。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 许多研究提供矛盾、不清晰或有限的数据。
  • 该重要领域亟需额外研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Polycystic ovary syndrome (PCOS) is a complex genetic trait and the most common endocrine disorder of women, clinically evident in 5% to 15% of reproductive-aged women globally, with associated cardiometabolic dysfunction. Adipose tissue (AT) dysfunction appears to play an important role in the pathophysiology of PCOS even in patients who do not have excess adiposity. METHODS: We undertook a systematic review concerning AT dysfunction in PCOS, and prioritized studies that assessed AT function directly. We also explored therapies that targeted AT dysfunction for the treatment of PCOS. RESULTS: Various mechanisms of AT dysfunction in PCOS were identified including dysregulation in storage capacity, hypoxia, and hyperplasia; impaired adipogenesis; impaired insulin signaling and glucose transport; dysregulated lipolysis and nonesterified free fatty acids (NEFAs) kinetics; adipokine and cytokine dysregulation and subacute inflammation; epigenetic dysregulation; and mitochondrial dysfunction and endoplasmic reticulum and oxidative stress. Decreased glucose transporter-4 expression and content in adipocytes, leading to decreased insulin-mediated glucose transport in AT, was a consistent abnormality despite no alterations in insulin binding or in IRS/PI3K/Akt signaling. Adiponectin secretion in response to cytokines/chemokines is affected in PCOS compared to controls. Interestingly, epigenetic modulation via DNA methylation and microRNA regulation appears to be important mechanisms underlying AT dysfunction in PCOS. CONCLUSION: AT dysfunction, more than AT distribution and excess adiposity, contributes to the metabolic and inflammation abnormalities of PCOS. Nonetheless, many studies provided contradictory, unclear, or limited data, highlighting the urgent need for additional research in this important field.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bril F, Ezeh U, Amiri M, et al. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome. J Clin Endocrinol Metab. 2023. PMID: 37329216. doi:10.1210/clinem/dgad356

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。